Insider Trading Alert - KMG, JBSS And TIS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, May 1, 2015, 63 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $200.00 to $4,632,380.28.

Highlighted Stocks Traded by Insiders:

KMG Chemicals (KMG) - FREE Research Report

Hatcher David L, who is 10% Owner at KMG Chemicals, sold 1,500 shares at $29.21 on May 1, 2015. Following this transaction, the 10% Owner owned 2.0 million shares meaning that the stake was reduced by 0.08% with the 1,500-share transaction.

The shares most recently traded at $29.90, up $0.69, or 2.31% since the insider transaction. Historical insider transactions for KMG Chemicals go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 25,500
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 30,500
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 30,500

The average volume for KMG Chemicals has been 61,800 shares per day over the past 30 days. KMG Chemicals has a market cap of $342.0 million and is part of the basic materials sector and chemicals industry. Shares are up 49.45% year-to-date as of the close of trading on Friday.

KMG Chemicals, Inc., through its subsidiaries, engages in the manufacture, formulation, and distribution of specialty chemicals in the United States, Mexico, Canada, Europe, Israel, and Singapore. It operates in two segments, Electronic Chemicals and Wood Treating Chemicals. The stock currently has a dividend yield of 0.41%. The company has a P/E ratio of 48.8. Currently, there is 1 analyst who rates KMG Chemicals a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KMG - FREE

TheStreet Quant Ratings rates KMG Chemicals as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full KMG Chemicals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

John B Sanfilippo & Son (JBSS) - FREE Research Report

Sanfilippo Jasper B, who is 10% Owner at John B Sanfilippo & Son, sold 13,049 shares at $51.68 on May 1, 2015. Following this transaction, the 10% Owner owned 0 shares meaning that the stake was reduced by 100% with the 13,049-share transaction.

Sanfilippo Jasper Brian Jr, who is COO, President at John B Sanfilippo & Son, sold 5,500 shares at $51.68 on May 1, 2015. Following this transaction, the COO, President owned 19,008 shares meaning that the stake was reduced by 22.44% with the 5,500-share transaction.

Sanfilippo James J, who is Director at John B Sanfilippo & Son, sold 1,975 shares at $51.68 on May 1, 2015. Following this transaction, the Director owned 1,622 shares meaning that the stake was reduced by 54.91% with the 1,975-share transaction.

Pellegrino Frank S, who is Sr. Vice President at John B Sanfilippo & Son, sold 2,500 shares at $52.00 on May 1, 2015. Following this transaction, the Sr. Vice President owned 17,128 shares meaning that the stake was reduced by 12.74% with the 2,500-share transaction.

The shares most recently traded at $51.76, down $0.24, or 0.46% since the insider transaction. Historical insider transactions for John B Sanfilippo & Son go as follows:

  • 4-Week # shares sold: 6,000
  • 12-Week # shares sold: 10,750
  • 24-Week # shares sold: 15,075

The average volume for John B Sanfilippo & Son has been 66,900 shares per day over the past 30 days. John B Sanfilippo & Son has a market cap of $444.1 million and is part of the consumer goods sector and food & beverage industry. Shares are up 13.96% year-to-date as of the close of trading on Friday.

John B. Sanfilippo & Son, Inc., together with its subsidiaries, processes and distributes peanuts and tree nuts in the United States. The company has a P/E ratio of 21.2. Currently, there are no analysts who rate John B Sanfilippo & Son a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JBSS - FREE

TheStreet Quant Ratings rates John B Sanfilippo & Son as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share, increase in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full John B Sanfilippo & Son Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Orchids Paper Products (TIS) - FREE Research Report

Schoen Jeffrey S, who is President & CEO at Orchids Paper Products, bought 2,500 shares at $21.61 on May 1, 2015. Following this transaction, the President & CEO owned 14,889 shares meaning that the stake was boosted by 20.18% with the 2,500-share transaction.

The shares most recently traded at $22.75, up $1.14, or 4.99% since the insider transaction. Historical insider transactions for Orchids Paper Products go as follows:

  • 4-Week # shares bought: 1,389
  • 4-Week # shares sold: 3,000
  • 12-Week # shares bought: 1,389
  • 12-Week # shares sold: 3,000
  • 24-Week # shares bought: 1,389
  • 24-Week # shares sold: 3,000

The average volume for Orchids Paper Products has been 69,600 shares per day over the past 30 days. Orchids Paper Products has a market cap of $188.2 million and is part of the consumer goods sector and consumer non-durables industry. Shares are down 24.6% year-to-date as of the close of trading on Friday.

Orchids Paper Products Company manufactures and sells tissue products for at-home and away from home markets in the United States. Its products include paper towels, bathroom tissues, and paper napkins. The stock currently has a dividend yield of 6.51%. The company has a P/E ratio of 19.4. Currently, there is 1 analyst who rates Orchids Paper Products a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TIS - FREE

TheStreet Quant Ratings rates Orchids Paper Products as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Orchids Paper Products Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Dow Falls, S&P 500 Trades Lower as P&G and Apple Slump

Dow Falls, S&P 500 Trades Lower as P&G and Apple Slump

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications

Video: Jim Cramer Reveals Why Stocks Are Moving Lower Thursday

Video: Jim Cramer Reveals Why Stocks Are Moving Lower Thursday